FDA panel calls for label changes, more education on menopausal hormone therapy

Disclosures: Simon reports receiving research support from AbbVie, Bayer Healthcare, Mylan/Viatris, and Myovant Sciences. He also serves as a consultant or advisor for Ascend Therapeutics, Bayer HealthCare Pharmaceuticals, Besins Healthcare, Biote Medical LLC, Cosette Pharmaceuticals, Femasys, Mayne Pharma, Pfizer, and Vella Biosciences. Simon has spoken for Ascend Therapeutics, Lawley Pharmaceuticals, Mayne Pharma, Myovant Sciences, and Pharmavite LLC, and holds stock in sermonix Pharmaceuticals. Faubion and Hirsch have no relevant financial disclosures to report. Healio was unable to confirm relevant financial disclosures for Hodis,Levy,Minkin,and pinkerton prior to publication.